✦ LIBER ✦

IFN-Β treatment cost driver in relapsing-remitting MS

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glatiramer acetate beats IFN-β therapies

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

IFN-β-1b plus pentoxifylline for relapsi

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 238 KB

Alemtuzumab superior to IFN-β-1a for rel

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Mitoxantrone as rescue therapy in worsen

✍ Jorge Correale; Carolina Rush; Alejandra Amengual; María Teresa Goicochea 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 243 KB

IFN-α-2a appears beneficial in relapsing

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 211 KB

Interferon-β-1a effective in relapsing-r

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 284 KB